Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Erika, Hitre"'
Publikováno v:
Pathology and Oncology Research, Vol 28 (2022)
Externí odkaz:
https://doaj.org/article/1dba3739fdfd4f558d3bfdc63a2c3e51
Publikováno v:
Pathology and Oncology Research, Vol 28 (2022)
Background: The literature data regarding colon cancer patients with liver-only metastases (CLM) show that NLR determined before metastasectomy is a prognostic marker of shorter relapse-free survival (RFS), but no results has been reported to date fo
Externí odkaz:
https://doaj.org/article/f8997d713a164e589099128b0af2f694
Autor:
Edoardo Isnaldi, François Richard, Giuseppe Marano, Patrizia Boracchi, Marion Maetens, Giuseppe Floris, Guy Jerusalem, Andrea Gombos, Alastair M. Thompson, Erika Hitre, Stefan Aebi, Marco Colleoni, Patrizia Dell’Orto, Roswitha Kammler, Patrick Neven, Giuseppe Viale, Meredith Regan, Elia Biganzoli, Christine Desmedt
Publikováno v:
Cancer Research. 83:P3-05
Background: The risk of late distant recurrence (≥ 5 years) in post-menopausal patients with ER+ BC remains significant even after standard adjuvant endocrine therapy (ET). Obesity, which has reached high proportions in Western Countries, is one of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25e851e6c26e987722564afa6c2a1bb9
https://doi.org/10.1158/1538-7445.sabcs22-p3-05-28
https://doi.org/10.1158/1538-7445.sabcs22-p3-05-28
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marco Colleoni, Meredith M. Regan, Massimo Barberis, Giuseppe Viale, Aron Goldhirsch, Angelo Di Leo, Seamus O’Reilly, Bettina Müller, Katsumasa Kuroi, Joaquín Gavilá, Sibylle Loibl, Christel Fontaine, Matthew Barber, Marie-Pascale Graas, Alastair Thompson, Vincenzo Di Lauro, Jacquie Chirgwin, Stefan Aebi, Per Karlsson, Ines Deleu, Andrea Gombos, Edda Simoncini, Guy Jerusalem, Erika Hitre, Patrick Neven, Roswitha Kammler, Elisabetta Munzone, Paola Rafaniello Raviele, Isabella Leone, Marta Rita Reforgiato, Caterina Fumagalli, Kathryn P. Gray, Elena Guerini-Rocco
Clinico-pathologic characteristics of patients according to NGS results (success/failure).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88105d26c666776be79dae0b724599f4
https://doi.org/10.1158/1078-0432.22478196
https://doi.org/10.1158/1078-0432.22478196
Autor:
Marco Colleoni, Meredith M. Regan, Massimo Barberis, Giuseppe Viale, Aron Goldhirsch, Angelo Di Leo, Seamus O’Reilly, Bettina Müller, Katsumasa Kuroi, Joaquín Gavilá, Sibylle Loibl, Christel Fontaine, Matthew Barber, Marie-Pascale Graas, Alastair Thompson, Vincenzo Di Lauro, Jacquie Chirgwin, Stefan Aebi, Per Karlsson, Ines Deleu, Andrea Gombos, Edda Simoncini, Guy Jerusalem, Erika Hitre, Patrick Neven, Roswitha Kammler, Elisabetta Munzone, Paola Rafaniello Raviele, Isabella Leone, Marta Rita Reforgiato, Caterina Fumagalli, Kathryn P. Gray, Elena Guerini-Rocco
Weighted Kaplan-Meier (KM) estimates of breast cancer-free interval (BCFI) and distant recurrence-free interval (DRFI) according to tumor subtype, separately by PIK3CA mutational status (mutated, MUT vs wild-type, WT). The 5-year event-free estimates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::457a4fad68d295e82df0aca78c82d694
https://doi.org/10.1158/1078-0432.22478199
https://doi.org/10.1158/1078-0432.22478199
Autor:
Marco Colleoni, Meredith M. Regan, Massimo Barberis, Giuseppe Viale, Aron Goldhirsch, Angelo Di Leo, Seamus O’Reilly, Bettina Müller, Katsumasa Kuroi, Joaquín Gavilá, Sibylle Loibl, Christel Fontaine, Matthew Barber, Marie-Pascale Graas, Alastair Thompson, Vincenzo Di Lauro, Jacquie Chirgwin, Stefan Aebi, Per Karlsson, Ines Deleu, Andrea Gombos, Edda Simoncini, Guy Jerusalem, Erika Hitre, Patrick Neven, Roswitha Kammler, Elisabetta Munzone, Paola Rafaniello Raviele, Isabella Leone, Marta Rita Reforgiato, Caterina Fumagalli, Kathryn P. Gray, Elena Guerini-Rocco
Purpose:Women with hormone receptor–positive early breast cancers have a persistent risk of relapse and biomarkers for late recurrence are needed. We sought to identify tumor genomic aberrations associated with increased late-recurrence risk.Experi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::964f9ff53513953d3bbd539a06b68ae9
https://doi.org/10.1158/1078-0432.c.6529881.v1
https://doi.org/10.1158/1078-0432.c.6529881.v1
Autor:
Oszkár Hahn, Attila Szijártó, Damján Pekli, András Fülöp, Bálint Kokas, Dávid Bárdos, Csilla András, Péter Bartek, István Battyáni, János Bezsilla, György Bodoky, Attila Bursics, Magdolna Dank, Zsófia Dankovics, Ákos Deák Pál, Kristóf Dede, Gyula Demeter, Attila Doros, Ibolyka Dudás, Zsófia Egyed, Róbert Farkas, Zsuzsanna Gerlei, Tamás Györke, Krisztina Hagymási, Erika Hitre, József Hőhn, Viktor Jancsik, Zsolt Káposztás, István Király, András Kiss, László Kóbori, Péter Kupcsulik, Gábor Lakatos, István Lázár, Tamás Lóderer, Endre Nagy, Attila Oláh, Péter Pajor, András Papp, Gabriella Pár, Mihály Patyánik, Ágota Petrányi, András Petri, László Piros, János Schuller, László Sikorszki, József Szabó, Eszter Székely, Andrea Szombati, László Torday, Judit Tóth, Lajos Barna Tóth, Edit Dósa, László Harsányi, Zsolt Horváth, Gábor István, László Landherr, György Lázár, Gabriella Lengyel, József Lővey, László Mangel, Pál Maurovich Horváth, Balázs Nemes, András Palkó, Zsuzsa Schaff, Ferenc Szalay, Ákos Szűcs, András Vereczkei
Publikováno v:
Orvosi Hetilap. 162:2-31
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::acc207e751e7a821756f87cc91a1b227
https://doi.org/10.1556/650.2021.32431
https://doi.org/10.1556/650.2021.32431
Autor:
Marcia S. Brose, Bruce G. Robinson, Steven I. Sherman, Barbara Jarzab, Chia‐Chi Lin, Fernanda Vaisman, Ana O. Hoff, Erika Hitre, Daniel W. Bowles, Suvajit Sen, Jennifer W. Oliver, Kamalika Banerjee, Bhumsuk Keam, Jaume Capdevila
Publikováno v:
Scientia
Cabozantinib; Differentiated thyroid cancer; Tyrosine kinase inhibitor Cabozantinib; Cáncer de tiroides diferenciado; Inhibidor de la tirosina quinasa Cabozantinib; Càncer de tiroides diferenciat; Inhibidor de la tirosina quinasa Background At an i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc2400d346c44558d06acd1a9a0ab68e
https://hdl.handle.net/11351/9657
https://hdl.handle.net/11351/9657
Autor:
Richard D. Gelber, Erika Hitre, Andrea Gombos, Alan S. Coates, Alastair M. Thompson, Sole Investigators, Barbara Ruepp, J Chirgwin, Bettina Müller, Marie-Pascale Graas, Stefan Aebi, Subrina Farah, Joaquín Gavilá, Patrick Neven, K. Ribi, A Courtois, Christian Marth, E Abdi, Per Karlsson, Harold J. Burstein, Katsumasa Kuroi, Seamus O'Reilly, A. Goldhirsch, Thomas Ruhstaller, S. Loibl, Manuela Rabaglio, Marco Colleoni, G. Jerusalem, Giulia Viale, C Kamby, Sherene Loi, Edda Simoncini, Meredith M. Regan
Publikováno v:
Annals of Oncology. 32:1256-1266
BACKGROUND Late recurrences in postmenopausal women with hormone receptor-positive breast cancers remain an important challenge. Avoidance or delayed development of resistance represents the main objective in extended endocrine therapy (ET). In anima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d13705e66773a2ac8689c3630b4e16a4
https://doi.org/10.1016/j.annonc.2021.07.017
https://doi.org/10.1016/j.annonc.2021.07.017